澳大利亚原住民和托雷斯海峡岛民的风湿病负担
Jason Sines1, Ken Cai1,2, Belinda Cashman3
1Department of Rheumatology, Westmead Hospital, Sydney, New South Wales, Australia.
Internal medicine journal
|August 13, 2024
概括
类风湿性关节炎和全身性红斑狼等类风湿病的患病率在澳大利亚土著人中有所不同. 需要更多的研究来了解这些社区的肌肉骨疼痛和其他疾病.
科学领域:
- 类风湿病学 类风湿病学
- 土著健康土著健康
- 流行病学 流行病学
背景情况:
- 风湿病症严重影响全球健康.
- 了解澳大利亚土著人口中的疾病患病率对于有针对性的医疗保健至关重要.
- 现有的关于澳大利亚土著人的类风湿病的数据有限.
研究的目的:
- 总结关于澳大利亚土著人中六种类型的风湿病的流行情况的当前知识.
- 发现有关这些疾病的研究缺口.
- 为未来的研究和临床实践提供信息.
主要方法:
- 在线医学文献数据库的系统搜索.
- 包括与澳大利亚土著人和特定的风湿病症相关的术语.
- 分析了45篇关于流行率的文章.
主要成果:
- 系统性红斑狼 (SLE) 在澳大利亚土著人中比非土著人更为普遍.
- 类风湿性关节炎 (RA) 在澳大利亚土著人中似乎不那么普遍.
- 肌肉骨 (MSK) 疼痛非常普遍和具有影响力,突出显示了对干预的重大需要.
结论:
- 关于澳大利亚土著人的类风湿病的数据非常少.
- 诸如自我报告,地理差异和获得医疗保健等因素可能会影响流行率数据.
- 进一步的社区合作研究对于确定类风湿病的真正负担和制定文化上适当的干预措施至关重要.
相关概念视频
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Chronic Bowel Disorders: Introduction
436
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
436
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
149
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
149
Inflammatory Bowel Disease II: Crohn's Disease
206
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
206
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
124
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
124


